| Literature DB >> 35415562 |
Viviana M Serra López1, Rikesh A Gandhi1, David P Falk1, Josh R Baxter1, John R Lien2, Benjamin L Gray1.
Abstract
Purpose: The purpose of this study was to compare the active range of motion in patients with thumb carpometacarpal (CMC) arthritis to healthy controls. A secondary objective of this study was to examine the feasibility of using wearable motion sensors in a clinical setting.Entities:
Keywords: Motion sensor; Range of motion; Thumb CMC arthritis
Year: 2021 PMID: 35415562 PMCID: PMC8991865 DOI: 10.1016/j.jhsg.2021.05.002
Source DB: PubMed Journal: J Hand Surg Glob Online ISSN: 2589-5141
Figure 1Average maximum thumb flexion and abduction across 3 trials of 4 asymptomatic extremities are shown, measured with standard goniometry and the electromagnetic motion sensor using the experimental setup. Bars demonstrate the 95% confidence interval for each measurement.
Figure 2Top view of the experimental setup is shown with the hand in the starting position, defined as 0° of abduction and extension. The motion sensor is embedded into a thumb interphalangeal joint immobilizer. This is connected to the electromagnetic motion sensor system, shown in the right lower corner of the image, which generates the electromagnetic field. The system’s electronic unit is shown in the left side of the image and interfaces with the host computer to calculate position and orientation.
Characteristics of Participants and Controls
| Characteristic | Participants | Controls |
|---|---|---|
| Number of participants | 19 | 12 |
| Median age (range) | 65 (35–83) | 65 (26–83) |
| Female sex, percentage | 68%, N = 13 | 75%, N = 9 |
| Number of extremities | 29 | 18 |
| Eaton classification (N = 29) | ||
| Stage 1 | 10.3%, N = 3 | |
| Stage 2 | 31.0%, N = 9 | |
| Stage 3 | 37.9%, N = 11 | |
| Stage 4 | 20.7%, N = 6 | |
| Previous treatments (N = 29) | ||
| Bracing | 46% | |
| CMC joint corticosteroid injection | 29% | |
| Hand therapy | 7% |
Sex and age are shown for the individual study participants.
Eaton classification stage is shown for the number of extremities tested.
Figure 3Circumduction curves for patients and controls. Arrowheads show the direction of motion during the trials. Error bars are shown at the value for average maximum abduction, extension, and flexion, demonstrating the 95% CI. Flexion is represented by negative numbers in the y axis.
Average Maximum Thumb Abduction, Extension, and Flexion in Extremities With Thumb CMC Joint Arthritis and Controls Across Trials
| Group Tested | Average Maximum Abduction, Degrees (SD) | Average Maximum Extension, Degrees (SD) | Average Maximum Flexion, Degrees (SD) | |||
|---|---|---|---|---|---|---|
| Controls | 70.8 (10.1) | - | 58.4 (9.1) | - | 39.9 (8.7) | - |
| Affected extremities | 53.9 (19.6) | .001 | 50.0 (15.2) | .019 | 33.5 (11.1) | .978 |
| Eaton stage 1 | 67.2 (22.1) | .321 | 62.5 (9.2) | .759 | 43.8 (4.2) | .233 |
| Eaton stage 2 | 68.8 (15.1) | .344 | 59.7 (12.4) | .617 | 33.8 (11.0) | .935 |
| Eaton stage 3 | 42.3 (14.6) | <.001 | 43.3 (14.3) | .001 | 29.0 (11.1) | .997 |
| Eaton stage 4 | 46.1 (17.0) | <.001 | 41.3 (12.6) | .001 | 36.1 (11.4) | .801 |
Listed P values are in comparison to the control group. For this reason, a P value is not reported in the “Controls” row.
Figure 4Scatter plots showing average maximum values for A abduction and B extension in degrees. 95% confidence intervals are indicated by dashed horizontal lines. Eaton stages are shown on the x axis.
Mean Difference in Maximum Thumb Abduction and Extension in Extremities With Thumb CMC Joint Arthritis Compared to Controls Across Trials
| Group Tested | Difference in Abduction Compared to Controls, Degrees (95% Confidence Interval) | Difference in Extension Compared to Controls, Degrees (95% Confidence Interval) |
|---|---|---|
| Affected extremities | 16.9 (12.6–21.2) | 8.4 (4.9–11.9) |
| Eaton stage 3 | 28.5 (25.0–32.0) | 15.1 (11.8–18.4) |
| Eaton stage 4 | 24.7 (20.8–28.6) | 17.1 (14.1–20.1) |